The influence of pharmacological manipulation of serotonergic and dopaminergic mechanisms on plasma prolactin in ovariectomized, estrogen-treated rats.
D006916:5-Hydroxytryptophan / Q000494:pharmacology*; D000818:Animals; D002369:Castration; D004967:Estrogens / Q000494:pharmacology*; D005260:Female; D005473:Fluoxetine / Q000494:pharmacology; D007700:Kinetics; D008784:Methysergide / Q000494:pharmacology; D011388:Prolactin / Q000097:blood*; D011804:Quinolines / Q000494:pharmacology*; D011814:Quipazine / Q000494:pharmacology*; D051381:Rats; D012701:Serotonin / Q000494:pharmacology*
D004967:Estrogens; D011804:Quinolines; D005473:Fluoxetine; D012701:Serotonin; D011814:Quipazine; D011388:Prolactin; D006916:5-Hydroxytryptophan; D008784:Methysergide